NuHope is proud to announce the addition of Dr. Adrianne (Patti) Smith, MD, as its Chief Medical Officer (CMO). In this role, Dr. Smith will work to build upon the mission established by NuHope’s founder, Dr. Adam Bruggeman and his dedicated team by offering outpatient treatment to those suffering from chronic pain and opioid dependency, in addition to a new preoperative assessment program.
The NuHope team is pleased to announce its PREOPTM Assessment Program under the guidance of Dr. Hussein Musa. Dr. Musa has been serving as one of NuHope’s Medical Providers and assumes the new position as Medical Director, taking on this additional leadership role as he helps the team launch the newly implemented PREOPTM
Social isolation mandates throughout Bexar County due to the COVID-19 pandemic pose a substantial risk for people in recovery from opioid dependency. One solution to the current situation is to encourage doctors to refer patients for one-on-one therapy for the time being. Behavioral therapy must continue to be a priority.
The Cochrane Database Review reveals several critical findings and has important shortcomings as well. The findings are only relevant to alcoholics anonymous and cannot be scientifically related to narcotics anonymous or other similar programs until a similar review is performed on those programs.
Dr. Adam Bruggeman bears the rare distinction of being the only physician in Texas- at least to his knowledge - of being dual board certified in orthopedics and addiction medicine. Read about his mission to tackle San Antonio's opioid problem on pages 127 - 128.
To the Editors of the Wall Street Journal Dr. Brian Barnett made an important point in his recent piece, (Feb. 6, 2020) “The 90 day prescription isn’t for everyone,” but the problem of matching treatment to patient is much larger than that, particularly in the issue of pain management, opioid prescription abuse and opioid addiction.
January 28, 2020, SAN ANTONIO, TX -Jeff Dunkel assumes the role of NuHope CEO following his position as Executive Vice President of Strategy at TITAN SPINE. NuHope is a San Antonio- based outpatient opioid and pain treatment center focused on taper effectiveness, which specifically reduces controlled substance use in those dependent on opioids.
Today’s opioid crisis requires no introduction. The deaths, costs and subsequent lawsuits have become front-page articles for many publications and news outlets. As awareness of the problem has increased, Congress has attempted to positively intervene by reducing legislative barriers and improving funding.
I think the narrative continues to be off. We are asking about why there are guidelines being applied to chronic pain patients and yet a patient dies from withdrawal presumably after being on high doses of medications. This is one of the items trying to be addressed...
December 10, 2019, SAN ANTONIO, TX - NuHope, an outpatient opioid and pain treatment center based in San Antonio, has completed its first year of operation with tremendous success. NuHope’s first year focused on taper effectiveness, which specifically reduces controlled substance use in those dependent on opioids.